![Dawn Kalmar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Kalmar
Public Communications Contact chez
STOKE THERAPEUTICS, INC.
Profil
Dawn Kalmar is currently Chief of Corporate Affairs & Strategic Partnership at Stoke Therapeutics, Inc. since 2025.
Formerly, Ms. Kalmar was Vice President-Corporate Communications at Vertex Pharmaceuticals, Inc. from 2010 to 2018.
Education includes an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Postes actifs de Dawn Kalmar
| Sociétés | Poste | Début |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Public Communications Contact | 01/04/2019 |
Anciens postes connus de Dawn Kalmar
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | 01/01/2018 |
Formation de Dawn Kalmar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
